Adult insulin dependent Americans will get a new cure, Afrezza insulin therapy, from the French manufacturer Sanofi and MannKind corporation. The licensing deal means that manufacturer will elaborate and put on sale Afrezza inhalated insulin therapy for diabetics.
Inhalated therapy can completely or partly replace the insuline injections and is a great scientific breakthrough in the battle against diabet. Affeza is planned to be launched in America at the begginning of 2015.
05:47 Samsung's smartphone share hit by Note7 debacle, stiff competition20
20:54 Groupon Buys LivingSocial, a Rival Once Valued at $6 Billion15
13:03 Waste Management 3rd-quarter earnings rise 11 percent11
18:37 Sumner Redstone forced to borrow $100 million from National Amusements: lawsuit13